Cigna: Select plans include coverage for tirzepatide, particularly for patients with comorbid conditions such as obesity and type 2 diabetes
Later, patients using these drugs reported unexpected weight loss due to reduced appetite, which shifted their use from diabetes treatment to mainstream weight-management therapy
Sodium-glucose transport protein 2 (SGLT2) inhibitors, StatPearls (2023) Genital infections with sodium glucose cotransporter-2 inhibitors: Occurrence and management in patients with Type 2 diabetes mellitus, Indian Journal of Endocrinology and Metabolism (2018) Preventing candidiasis, Centers for Disease Control and Prevention (2024) Jardiance, DailyMed (2024) Ozempic, DailyMed (2023) Glucagon-like peptide-1 receptor agonists, StatPearls (2024) Patient education: Vaginal yeast infection (Beyond the Basics), UpToDate (2023) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Therefore, the use of stable isotope-labelled standards, whenever possible, is recommended to correct for matrix effects and achieve more accurate, precise, and reliable quantification
Endocrinology Teams Top Recommendation We are a team of endocrinology experts, most of whom have personally experienced obesity and its related complications
The best-known published abdominal-fat outcomes are usually discussed over about 26 weeks
